echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > Breast cancer is preventable and treatable, entering the era of "chronic disease"

    Breast cancer is preventable and treatable, entering the era of "chronic disease"

    • Last Update: 2022-09-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Statistics from the National Cancer Center in 2019 show that in 2015, there were about 304,000 new cases of breast cancer in Chinese women, accounting for 17.


    "Although advanced breast cancer is currently incurable, optimizing the treatment mode and improving the availability of innovative drugs can help patients with advanced stage relieve their clinical symptoms, improve their quality of life, and further prolong their survival time


    Treatment methods and strategies continue to increase and optimize, and breast cancer has gradually become a treatable and controllable "chronic disease"

    In the past ten years, from surgical treatment, chemotherapy, endocrine therapy to today's targeted therapy, various treatment methods for advanced breast cancer have been emerging and changing, especially the optimization of treatment strategies from "single" to "combination", which has brought about domestic advanced breast cancer.


    "Today is the era of precision treatment.


    Breast cancer is preventable and curable, and every advanced patient should not give up lightly

    Professor Sun Qiang told reporters: "Currently, there are many treatments for breast cancer.


    Targeted therapy is a new type of therapy developed in recent years with the emergence of targeted drugs


    "This sends a message to female friends: breast cancer is preventable and curable


    Targeted drugs and combination therapy prolong patient survival, and high-quality innovative drugs should be included in the medical insurance system

    In breast cancer, hormone receptor-positive (HR+) patients account for about 65%, and hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced patients account for about 5% to 10%


    "Endocrine therapy is an important treatment for patients with HR-positive advanced breast cancer because of its good efficacy and safety, but there is a problem of drug resistance


    Experts also called for improving the availability of breast cancer treatment drugs, and high-quality innovative drugs should be included in the medical insurance system, so that more patients with advanced breast cancer can receive the most effective treatment, and help realize the "Healthy China Action (2019-2030)" The proposed 5-year overall cancer survival rate by 2022 is no less than a target of 43.


    Early detection of breast cancer is of great significance, and attention should be paid to annual physical examinations and monthly breast self-examinations

    Experts also hope to send a message to the majority of women: breast cancer is preventable, treatable and curable, but early detection is of great significance


    "Although this topic is relatively old, as a breast surgeon, I especially hope to let all women know the importance of early detection through publicity




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.